CROHN'S DISEASE AGGRAVATED

Clinical trials for CROHN'S DISEASE AGGRAVATED explained in plain language.

Never miss a new study

Get alerted when new CROHN'S DISEASE AGGRAVATED trials appear

Sign up with your email to follow new studies for CROHN'S DISEASE AGGRAVATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Head-to-Head showdown: which drug works better for tough Crohn's cases?

Disease control Not yet recruiting

This study directly compares two newer medications, ustekinumab (an injection) and upadacitinib (a pill), for people with Crohn's disease that hasn't responded well to standard treatments. It will enroll 454 adults who previously failed on common biologic drugs like infliximab or…

Matched conditions: CROHN'S DISEASE AGGRAVATED

Phase: PHASE3 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

CROHN&#39;S DISEASE AGGRAVATED

Get alerted when new CROHN&#39;S DISEASE AGGRAVATED trials appear

Head-to-Head showdown: which drug works better for tough Crohn's cases?

CROHN'S DISEASE AGGRAVATED

Get alerted when new CROHN'S DISEASE AGGRAVATED trials appear